रोमानिया - रोमानियाई - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

laboratorios leon farma, s.a. - spania - combinatii (etinilestradiolum + drospirenonum) - compr. film. - 0,02mg+3mg - contraceptive hormonale pentru uz sistemic progesteroni si estrogeni combinatii fixe

रोमानिया - रोमानियाई - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

gedeon richter plc. - ungaria - combinatii (desogestrelum+etinilestradiolum) - compr. film. - 0,15mg/0,03mg - contraceptive hormonale pentru uz sistemic progesteroni si estrogeni combinatii fixe

यूरोपीय संघ - रोमानियाई - EMA (European Medicines Agency)

novavax cz, a.s. - sars cov-2 (original) recombinant spike protein, sars-cov-2 (omicron xbb.1.5) recombinant spike protein - covid-19 virus infection - covid-19 vaccines - nuvaxovid is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older. utilizarea acestui vaccin ar trebui să fie în conformitate cu recomandările oficiale. nuvaxovid xbb. 5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older. utilizarea acestui vaccin ar trebui să fie în conformitate cu recomandările oficiale.

यूरोपीय संघ - रोमानियाई - EMA (European Medicines Agency)

vifor fresenius medical care renal pharma france - avacopan - microscopic polyangiitis; wegener granulomatosis - imunosupresoare - tavneos, in combination with a rituximab or cyclophosphamide regimen, is indicated for the treatment of adult patients with severe, active granulomatosis with polyangiitis (gpa) or microscopic polyangiitis (mpa).

यूरोपीय संघ - रोमानियाई - EMA (European Medicines Agency)

nordic group b.v. - metotrexat - arthritis, psoriatic; psoriasis; arthritis, juvenile rheumatoid; arthritis, rheumatoid - agenți antineoplazici - nordimet is indicated for the treatment of:active rheumatoid arthritis in adult patients,polyarthritic forms of severe, active juvenile idiopathic arthritis (jia), when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate,moderate to severe plaque psoriasis in adults who are candidates for systemic therapy, and severe psoriatic arthritis in adult patients, induction of remission in moderate steroid-dependent crohn's disease in adult patients, in combination with corticosteroids and for maintenance of remission, as monotherapy, in patients who have responded to methotrexate.

रोमानिया - रोमानियाई - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

laboratorios leon farma, s.a. - spania - combinatii ( etinilestradiolum + drospirenonum) - compr. film. - 0,02mg/3mg - contraceptive hormonale pentru uz sistemic progesteroni si estrogeni combinatii fixe

यूरोपीय संघ - रोमानियाई - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - upadacitinib - artrita, reumatoida - imunosupresoare - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.  crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.

रोमानिया - रोमानियाई - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

gedeon richter plc. - ungaria - combinatii (clormadinona+etinilestradiol) - compr. film. - 2mg/0,03mg - contraceptive hormonale pentru uz sistemic progesteroni si estrogeni combinatii fixe

यूरोपीय संघ - रोमानियाई - EMA (European Medicines Agency)

eli lilly nederland b.v. - mirikizumab - colită, ulcerativă - imunosupresoare - omvoh is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.

यूरोपीय संघ - रोमानियाई - EMA (European Medicines Agency)

ucb pharma sa  - certolizumab pegol - artrita, reumatoida - imunosupresoare - poliartrita arthritiscimzia, în asociere cu metotrexat (mtx), este indicat pentru:tratamentul moderată până la severă, cu artrită reumatoidă activă (pr) la pacienții adulți, atunci când răspunsul la medicamente antireumatice modificatoare ale bolii (marmb), inclusiv mtx, a fost inadecvat. cimzia poate fi administrat în monoterapie în caz de intoleranță la mtx sau atunci când continuarea tratamentului cu mtx este inappropriatethe tratament de active, severe și progresive, la ra la adulți nu au fost tratați anterior cu mtx sau alte dmard.. cimzia a fost demonstrat de a reduce rata progresiei distrucției articulare de raze x și de a îmbunătăți funcția fizică, atunci când este administrată în combinație cu mtx. spondilartrita axială cimzia este indicat pentru tratamentul pacienților adulți cu active severe, spondilartrita axială, care cuprinde:spondilita anchilozantă (sa)adulți cu spondilită anchilozantă activă severă care au avut un răspuns inadecvat sau intoleranță la antiinflamatoarele nesteroidiene (ains). sp